Irenic Capital Management LP Makes New $1.23 Million Investment in The Cooper Companies, Inc. $COO

Irenic Capital Management LP bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 15,000 shares of the medical device company’s stock, valued at approximately $1,229,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after buying an additional 7,363 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of Cooper Companies by 115.8% during the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after buying an additional 73,165 shares in the last quarter. Cresset Asset Management LLC acquired a new position in shares of Cooper Companies during the second quarter worth $291,000. Cerity Partners LLC increased its holdings in shares of Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after buying an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its stake in shares of Cooper Companies by 2.8% in the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after purchasing an additional 973 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

Shares of COO opened at $65.05 on Thursday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The stock has a 50-day moving average of $64.58 and a 200-day moving average of $74.10. The company has a market cap of $12.69 billion, a PE ratio of 55.13, a P/E/G ratio of 1.76 and a beta of 0.87. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the business earned $0.96 EPS. The company’s quarterly revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of several analyst reports. BNP Paribas Exane lowered their target price on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research report on Monday, June 8th. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Citigroup reaffirmed a “neutral” rating and set a $69.00 target price (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. Barclays raised their target price on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Finally, Piper Sandler set a $86.00 target price on Cooper Companies and gave the stock an “overweight” rating in a research report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and a consensus price target of $81.31.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.